295 related articles for article (PubMed ID: 30225610)
21. Utility of virtual touch quantification in the diagnosis of pancreatic ductal adenocarcinoma.
Onoyama T; Koda M; Fujise Y; Takata T; Kawata S; Okamoto T; Miyoshi K; Matono T; Sugihara T; Matsumoto K; Kawaguchi K; Harada K; Yashima K; Isomoto H
Clin Imaging; 2017; 42():64-67. PubMed ID: 27886609
[TBL] [Abstract][Full Text] [Related]
22. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
23. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
[TBL] [Abstract][Full Text] [Related]
24. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
25. Isoattenuating insulinomas at biphasic contrast-enhanced CT: frequency, clinicopathologic features and perfusion characteristics.
Zhu L; Xue HD; Sun H; Wang X; He YL; Jin ZY; Zhao YP
Eur Radiol; 2016 Oct; 26(10):3697-705. PubMed ID: 26815370
[TBL] [Abstract][Full Text] [Related]
26. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, corona, and attraction signs.
Beker K; Lee KS; Tsai LL; Hegazi T; Garces-Descovich A; Brook A; Mortele KJ
Abdom Radiol (NY); 2019 Dec; 44(12):4048-4056. PubMed ID: 31352623
[TBL] [Abstract][Full Text] [Related]
28. Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.
Mayer P; Fritz F; Koell M; Skornitzke S; Bergmann F; Gaida MM; Hackert T; Maier-Hein K; Laun FB; Kauczor HU; Grenacher L; Klauß M; Stiller W
Cancer Imaging; 2021 Jan; 21(1):13. PubMed ID: 33468259
[TBL] [Abstract][Full Text] [Related]
29. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
[No Abstract] [Full Text] [Related]
30. Chronic Pancreatitis or Pancreatic Tumor? A Problem-solving Approach.
Wolske KM; Ponnatapura J; Kolokythas O; Burke LMB; Tappouni R; Lalwani N
Radiographics; 2019; 39(7):1965-1982. PubMed ID: 31584860
[TBL] [Abstract][Full Text] [Related]
31. 3 T MR perfusion of solid pancreatic lesions using dynamic contrast-enhanced DISCO sequence: Usefulness of qualitative and quantitative analyses in a pilot study.
Donati F; Boraschi P; Cervelli R; Pacciardi F; Lombardo C; Boggi U; Falaschi F; Caramella D
Magn Reson Imaging; 2019 Jun; 59():105-113. PubMed ID: 30878601
[TBL] [Abstract][Full Text] [Related]
32. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
[TBL] [Abstract][Full Text] [Related]
33. Is there any clinical or radiologic feature as a preoperative marker for differentiating mass-forming pancreatitis from early-stage pancreatic adenocarcinoma?
Lee H; Lee JK; Kang SS; Choi D; Jang KT; Kim JH; Lee KT; Paik SW; Yoo BC; Rhee JC
Hepatogastroenterology; 2007; 54(79):2134-40. PubMed ID: 18251176
[TBL] [Abstract][Full Text] [Related]
34. Assessment of tumor heterogeneity: Differentiation of periampullary neoplasms based on CT whole-lesion histogram analysis.
Lu J; Hu D; Tang H; Hu X; Shen Y; Li Z; Peng Y; Kamel I
Eur J Radiol; 2019 Jun; 115():1-9. PubMed ID: 31084752
[TBL] [Abstract][Full Text] [Related]
35. Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions.
Deng Y; Ming B; Zhou T; Wu JL; Chen Y; Liu P; Zhang J; Zhang SY; Chen TW; Zhang XM
Front Oncol; 2021; 11():620981. PubMed ID: 33842325
[TBL] [Abstract][Full Text] [Related]
36. Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.
Haj-Mirzaian A; Kawamoto S; Zaheer A; Hruban RH; Fishman EK; Chu LC
Abdom Radiol (NY); 2020 Feb; 45(2):457-478. PubMed ID: 31897686
[TBL] [Abstract][Full Text] [Related]
37. Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.
Loizou L; Albiin N; Leidner B; Axelsson E; Fischer MA; Grigoriadis A; Del Chiaro M; Segersvärd R; Verbeke C; Sundin A; Kartalis N
Eur Radiol; 2016 Nov; 26(11):4021-4029. PubMed ID: 26965503
[TBL] [Abstract][Full Text] [Related]
38. Optimized ROI size on ADC measurements of normal pancreas, pancreatic cancer and mass-forming chronic pancreatitis.
Ma C; Li J; Boukar MB; Yang P; Wang L; Chen L; Su L; Qu J; Chen SY; Hao Q; Lu JP
Oncotarget; 2017 Nov; 8(58):99085-99092. PubMed ID: 29228754
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
40. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and ductal pancreatic adenocarcinoma.
Iglesias-García J; Lindkvist B; Lariño-Noia J; Domínguez-Muñoz JE
Rev Esp Enferm Dig; 2012 Jun; 104(6):315-21. PubMed ID: 22738702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
